Skip to main content
. 2011 Jun;4(2):23–31. doi: 10.1111/j.1753-5174.2011.00034.x

Table 3a.

CTCAE grade ≥3 events reported by any patient

Patients with grade ≥3 event, N (%)
AZD4877 dose

10 mg (N = 3) 15 mg (N = 3) 20 mg (N = 6) 25 mg (N = 6) Total (N = 18)
Any grade ≥3 event 0 0 1 (17) 2 (33) 3 (17)
Febrile neutropenia 0 0 0 1 (17) 1 (6)
Neutropenia 0 0 1 (17) 0 1 (6)
Constipation 0 0 0 1 (17) 1 (6)
Fatigue 0 0 0 1 (17) 1 (6)
Urinary tract infection 0 0 0 1 (17) 1 (6)
Anorexia 0 0 0 1 (17) 1 (6)